Ex vivo culturing of stromal cells with dexamethasone-loaded carboxymethylchitosan/poly(amidoamine) dendrimer nanoparticles promotes ectopic bone formation

Bone

Volumn 46, Issue 5, 2010, Pages 1424-1435

  Oliveira, J M ^a,b   Kotobuki, N ^b   Tadokoro, M ^b   Hirose, M ^b   Mano, J F ^a   Reis, R L ^a   Ohgushi, H ^b  

^a UNIVERSITY OF MINHO   (Portugal)

^b NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

Author keywords

Bone histomorphometry; Bone marrow stromal cells; Dexamethasone loaded carboxymethylchitosan poly(amidoamine) dendrimer nanoparticles; Hydroxyapatite; In vivo test

Indexed keywords

ALKALINE PHOSPHATASE BONE ISOENZYME; CARBOXYMETHYLCHITOSAN POLY(AMIDOAMINE) DENDRIMER NANOPARTICLE; DENDRIMER; DEX; DEXAMETHASONE; EOSIN; HEMATOXYLIN; HYDROXYAPATITE; NANOPARTICLE; OSTEOCALCIN; PROTEOGLYCAN; TISSUE SCAFFOLD; TOLONIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DENSITY; BONE MARROW STROMAL CELL; CELL COUNT; CELL CULTURE; CELL DIFFERENTIATION; CELL EXPANSION; CONTROLLED STUDY; EX VIVO STUDY; EXPLANT; EXTRACELLULAR MATRIX; IMPLANTATION; MALE; MICRO-COMPUTED TOMOGRAPHY; MORPHOMETRICS; NONHUMAN; OSSIFICATION; POROSITY; QUANTITATIVE ANALYSIS; RAT; STAINING; STROMA CELL;

ALKALINE PHOSPHATASE; ANIMALS; CELLS, CULTURED; CHITOSAN; DENDRIMERS; DEXAMETHASONE; DURAPATITE; MALE; MICROSCOPY; NANOPARTICLES; OSTEOCALCIN; OSTEOGENESIS; RATS; RATS, INBRED F344; STROMAL CELLS; TISSUE ENGINEERING; TISSUE SCAFFOLDS; X-RAY MICROTOMOGRAPHY;

EID: 77951258512     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2010.02.007     Document Type: Article

References (57)

1. Chu T.M.G., Orton D.G., Hollister S.J., Feinberg S.E., Halloran J.W. Mechanical and in vivo performance of hydroxyapatite implants with controlled architectures. Biomaterials 2002, 23(5):1283-1293.
2. Schnettler R., Alt V., Dingeldein E., Pfefferle H.-J., Kilian O., Meyer C., et al. Bone ingrowth in bFGF-coated hydroxyapatite ceramic implants. Biomaterials 2003, 24(25):4603-4608.
3. Jones A.C., Arns C.H., Sheppard A.P., Hutmacher D.W., Milthorpe B.K., Knackstedt M.A. Assessment of bone ingrowth into porous biomaterials using micro-CT. Biomaterials 2007, 28(15):2491-2504.
4. Woodard J.R., Hilldore A.J., Lan S.K., Park C.J., Morgan A.W., Eurell J.A.C., et al. The mechanical properties and osteoconductivity of hydroxyapatite bone scaffolds with multi-scale porosity. Biomaterials 2007, 28(1):45-54.
5. Boyde A., Corsi A., Quarto R., Cancedda R., Bianco P. Osteoconduction in large macroporous hydroxyapatite ceramic implants: evidence for a complementary integration and disintegration mechanism. Bone 1999, 24(6):579-589.
6. Kozo O., Yamamuro T., Nakamura T., Kokubo T. Quantitative study on osteoconduction of apatite-wollastonite containing glass ceramic granules, hydroxyapatite granules and alumina granules. Biomaterials 1990, 11(4):265-271.
7. Kurashina K., Kurita H., Takeuchi H., Hirano N., Klein C.P.A.T., de Groot K. Osteogenesis in muscle with composite graft of hydroxyapatite and autogenous calvarial periostium: a preliminary report. Biomaterials 1995, 16(2):119-123.
8. Arinzeh T.L., Tran T., McAlary J., Daculsi G. A comparative study of biphasic calcium phosphate ceramics for human mesenchymal stem-cell-induced bone formation. Biomaterials 2005, 26(17):3631-3638.
9. Kim H., Suh H., Jo S.A., Kim H.W., Lee J.M., Kim E.H., et al. In vivo bone formation by human marrow stromal cells in biodegradable scaffolds that release dexamethasone and ascorbate-2-phosphate. Biochem Biophys Res Commun 2005, 332(4):1053-1060.
10. Nishikawa M., Myoui A., Ohgushi H., Ikeuchi M., Tamai N., Yoshikawa H. Bone Tissue engineering using novel interconnected porous hydroxyapaptite ceramics combined with marrow mesenchymal cells: quantitative and three-dimensional image analysis. Cell Transplant 2004, 13:367-376.
11. Uemura T., Dong J., Wang Y., Kojima H., Saito T., Iejima D., et al. Transplantation of cultured bone cells using combinations of scaffolds and culture techniques. Biomaterials 2003, 24(13):2277-2286.
12. Hosseinkhani H., Yamamoto M., Inatsugu Y., Hiraoka Y., Inoue S., Shimokawa H., et al. Enhanced ectopic bone formation using a combination of plasmid DNA impregnation into 3-D scaffold and bioreactor perfusion culture. Biomaterials 2006, 27(8):1387-1398.
13. Kruyt M.C., Dhert W.J.A., Oner F.C., van Blitterswijk C.A., Verbout A.J., de Bruijn J.D. Analysis of ectopic and orthotopic bone formation in cell-based tissue-engineered constructs in goats. Biomaterials 2007, 28(10):1798-1805.
14. Srouji S., Livne E. Bone marrow stem cells and biological scaffold for bone repair in aging and disease. Mech Ageing Dev 2005, 126(2):281-287.
15. Bianco P., Robey P.G. Stem cells in tissue engineering. Nature 2001, 414:118-121.
16. Karussis D., Kassis I., Kurkalli B.G.S., Slavin S. Immunomodulation and neuroprotection with mesenchymal bone marrow stem cells (MSCs): a proposed treatment for multiple sclerosis and other neuroimmunological/neurodegenerative diseases. J Neurol Sci 2008, 265(1-2):131-135.
17. Hou M., Yang K.-M., Zhang H., Zhu W.-Q., Duan F.-J., Wang H., et al. Transplantation of mesenchymal stem cells from human bone marrow improves damaged heart function in rats. Int J Cardiol 2007, 115(2):220-228.
18. Liu W., Cui L., Cao Y., Klimanskaya Irina, Robert L. Bone reconstruction with bone marrow stromal cells. Methods in enzymology 2006, 362. Academic Press.
19. Banfi A., Muraglia A., Dozin B., Mastrogiacomo M., Cancedda R., Quarto R. Proliferation kinetics and differentiation potential of ex vivo expanded human bone marrow stromal cells: implications for their use in cell therapy. Exp Hematol 2000, 28(6):707-715.
20. Krampera M., Pizzolo G., Aprili G., Franchini M. Mesenchymal stem cells for bone, cartilage, tendon and skeletal muscle repair. Bone 2006, 39(4):678-683.
21. Mauney J.R., Jaquiery C., Volloch V., Heberer M., Martin I., Kaplan D.L. In vitro and in vivo evaluation of differentially demineralized cancellous bone scaffolds combined with human bone marrow stromal cells for tissue engineering. Biomaterials 2005, 26(16):3173-3185.
22. Ogston N., Harrison A.J., Cheung H.F.J., Ashton B.A., Hampson G. Dexamethasone and retinoic acid differentially regulate growth and differentiation in an immortalised human clonal bone marrow stromal cell line with osteoblastic characteristics. Steroids 2002, 67:895-906.
23. Eijken M., Koedam M., van Driel M., Buurman C.J., Pols H.A.P., van Leeuwen J.P.T.M. The essential role of glucocorticoids for proper human osteoblast differentiation and matrix mineralization. Mol Cell Endocrinol 2006, 248:87-93.
24. Blum J.S., Brandon Parrott M., Mikos A.G., Barry M.A. Early osteoblastic differentiation induced by dexamethasone enhances adenoviral gene delivery to marrow stromal cells. J Orthop Res 2004, 22(2):411-416.
25. Jorgensen N.R., Henriksen Z., Sorensen O.H., Civitelli R. Dexamethasone, BMP-2, and 1, 25-dihydroxyvitamin D enhance a more differentiated osteoblast phenotype: validation of an in vitro model for human bone marrow-derived primary osteoblasts. Steroids 2004, 69(4):219-226.
26. Holtorf H.L., Jansen J.A., Mikos A.G. Ectopic bone formation in rat marrow stromal cell/titanium fiber mesh scaffold constructs: effect of initial cell phenotype. Biomaterials 2005, 26(31):6208-6216.
27. Porter R.M., Huckle W.R., Goldstein A.S. Effect of dexamethasone withdrawal on osteoblastic differentiation of bone marrow stromal cells. J Cell Biochem 2003, 90:13-22.
28. Castano-Izquierdo H., Álvarez-Barreto J., van den Dolder J., Jansen J.A., Mikos A.G., Sikavitsas V.I. Pre-culture period of mesenchymal stem cells in osteogenic media influences their in vivo bone forming potential. J Biomed Mater Res, Part A 2007, 82:129-138.
29. Mountziaris P.M., Mikos A.G. Modulation of the inflammatory response for enhanced bone tissue regeneration. Tissue Eng, Part B 2008, 14:179-186.
30. Hayashi R., Wada H., Ito K., Adcock I.M. Effects of glucocorticoids on gene transcription. Eur J Pharmacol 2004, 500:51-62.
31. Schäcke H., Döcke W.D., Asadullah K. Mechanisms involved in the side effects of glucocorticoids. Pharmacol Ther 2002, 96:23-43.
32. Oliveira J.M., Kotobuki N., Marques A.P., Pirraco R.P., Benesch J., Hirose M., et al. Surface engineered carboxymethylchitosan/poly(amidoamine) dendrimer nanoparticles for intracellular targeting. Adv Funct Mater 2008, 18:1840-1853.
33. Intracellular Carboxymethylchitosan/Poly(amidoamine) Nanocarriers Loaded with Dexamethasone Enhances Osteogenic Differentiation of RBMSCs In Vitro. Tissue Eng 2007, 1719. London, UK. J.M. Oliveira, N. Kotobuki, M. Hirose, J.F. Mano, R.L. Reis, H. Ohgushi (Eds.).
34. Oliveira J.M., Silva S.S., Malafaya P.B., Rodrigues M.T., Gomes M.E., Kotobuki N., et al. Macroporous hydroxyapatite scaffolds for bone tissue engineering applications: physicochemical characterization and assessment of rat bone marrow stromal cells viability. J Biomed Mater Res, Part A 2009, 91(1):175-186.
35. Oliveira J.M., Sousa R.A., Kotobuki N., Tadokoro M., Hirose M., et al. The osteogenic differentiation of rat bone marrow stromal cells cultured with dexamethasone-loaded carboxymethylchitosan/poly(amidoamine) dendrimer nanoparticles. Biomaterials 2008, 30(5):804-813.
36. Ito A., Ohtsuka M., Kawamura H., Ikeuchi M., Ohgushi H., Sogo Y., et al. Zinc-containing tricalcium phosphate and related materials for promoting bone formation. Curr Appl Phys 2005, 5:402-406.
37. Kasten P., Vogel J., Luginbuhl R., Niemeyer P., Tonak M., Lorenz H., et al. Ectopic bone formation associated with mesenchymal stem cells in a resorbable calcium deficient hydroxyapatite carrier. Biomaterials 2005, 26(29):5879-5889.
38. Haynesworth S.E., Goshima J., Goldberg V.M., Caplan A.I. Characterization of cells with osteogenic potential from human marrow. Bone 1992, 13:81-88.
39. Beck G.R., Zerler B., Moran E. Phosphate is a specific signal for induction of osteopontin gene expression. Proc Natl Acad Sci 2000, 97:8352-8357.
40. Harris H. The human alkaline phosphatases: what we know and what we don't know. Clin Chim Acta 1989, 186:133-150.
41. Oliveira J.M., Silva S.S., Mano J.F., Reis R.L. Innovative technique for the preparation of porous bilayer hydroxyapatite/chitosan scaffolds for osteochondral applications 2006, 927-930. Key Eng Mater, Trans Tech Pub, Kyoto (JPN), Zurich, Switzerland.
42. Oliveira J.M., Rodrigues M.T., Silva S.S., Malafaya P.B., Gomes M.E., Viegas C.A., et al. Novel hydroxyapatite/chitosan bilayered scaffold for osteochondral tissue-engineering applications: scaffold design and its performance when seeded with goat bone marrow stromal cells. Biomaterials 2006, 27(36):6123-6137.
43. Chen X.-G., Park H.-J. Chemical characteristics of O-carboxymethyl chitosans related to the preparation conditions. Carbohydr Polymer 2003, 53:355-359.
44. Kihara T., Oshima A., Hirose M., Ohgushi H. Three-dimensional visualization analysis of in vitro cultured bone fabricated by rat marrow mesenchymal stem cells. Biochem Biophys Res Commun 2004, 316:943-948.
45. Kotobuki N., Motohiro H., Machida H., Katou Y., Muraki K., Takakura Y., et al. Viability and osteogenic potential of cryopreserved human bone marrow-derived mesenchymal cells. Tissue Eng 2005, 11:663-673.
46. Tadokoro M., Hattori Y., Ohgushi H. Rapid preparation of fresh frozen tissue-engineered bone sections for histological, histomorphometrical and histochemical analyses. Biomed Mater Eng 2006, 16:405-413.
47. Muller R., Van Campenhout H., Van Damme B., Van der Perre G., Dequeker J., Hildebrand T., et al. Morphometric analysis of human bone biopsies: a quantitative structural comparison of histological sections and micro-computed tomography. Bone 1998, 23(1):59-66.
48. Zeltinger J., Sherwood J.K., Graham D.A., Mueller R., Griffith L.G. Effect of pore size and void fraction on cellular adhesion, proliferation, and matrix deposition. Tissue Eng 2001, 7:557-572.
49. Simon J.L., Roy T.D., Parsons J.R., Rekow E.D., Thompson V.P., Kemnitzer J., et al. Engineered cellular response to scaffold architecture in a rabbit trephine defect. J Biomed Mater Res, Part A 2003, 66A:275-282.
50. Tamai N., Myoui A., Tomita T., Nakase T., Tanaka J., Ochi T., et al. Novel hydroxyapatite ceramics with an interconnective porous structure exhibit superior osteoconduction in vivo. J Biomed Mater Res 2002, 59:110-117.
51. Hicok K.C., Thomas T., Gori F., Rickard D.J., Spelsberg T.C., Riggs B.L. Development and characterisation of conditionally immortalised osteoblast precursor cell lines from human bone marrow stroma. J Bone Miner Res 1998, 13:205-217.
52. Mahonen A., Jukkola A., Risteli L., Risteli J., Maenpaa P.H. Type 1 procollagen synthesis is regulated by steroids and related hormones in human osteosarcoma cells. J Cell Biochem 1998, 68:151-163.
53. Chen G., Liu D., Tadokoro M., Hirochika R., Ohgushi H., Tanaka J., et al. Chondrogenic differentiation of human mesenchymal stem cells cultured in a cobweb-like biodegradable scaffold. Biochem Biophys Res Commun 2004, 322(1):50-55.
54. Wong M.M., Rao L.G., Ly H., Hamilton L., Tong J., Sturtridge W., et al. Long-term effects of physiologic concentrations of dexamethasone on human bone-derived cells. J Bone Miner Res 1990, 5:803-813.
55. Kondo H., Ohyama T., Ohya K., Kasugai S. Temporal changes of mRNA expression of matrix proteins and parathyroid hormone related protein (PTH/PTH-rp) receptor in bone development. J Bone Miner Res 1997, 12:2089-2097.
56. Owen T.A., Aronow M., Shalhoub V., Barone L.M., Wilming L., Tassinari M.S., et al. Reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of bone extracellular matrix. J Cell Physiol 1990, 143:420-430.
57. Malaval L., Modrowski D., Gupta A.K., Aubin J.E. Cellular expression of bone related proteins during in vitro osteogenesis in rat bone marrow stromal cultures. J Cell Physiol 1994, 138:555-572.